Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | LTA4H | P09960 | 3/20 | 0.59 |
| ▸ | HTR1B | P28222 | 2/20 | 0.53 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.52 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.52 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3010867 | 0.94 | KCNA3 (0.67) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 | |
| SCHEMBL215246 | 0.89 | KCNA3 (0.58) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 | |
| Water SCHEMBL16581630 | 0.87 | KCNA3 (0.56) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 | |
| SCHEMBL6555976 | 0.87 | KCNA3 (0.56) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 | |
| SCHEMBL6558495 | 0.87 | KCNA3 (0.56) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 | |
| SCHEMBL30693772 | 0.87 | KCNA3 (0.56) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 | |
| SCHEMBL11137717 | 0.87 | KCNA3 (0.56) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 | |
| SCHEMBL2844283 | 0.86 | KCNA3 (0.75) | KCNA3LTA4HHTR1BRECQLTAAR1 | |
| SCHEMBL3369424 | 0.85 | LTA4H (0.62) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 | |
| SCHEMBL7241377 | 0.85 | LTA4H (0.74) | KCNA3SMN1; SMN2LTA4HHTR1BCHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2644404-B1 | INK COMPOSITION, IMAGE FORMING METHOD, AND PRINTED ARTICLE | FUJIFILM CORP (JP) | 2017-08-16 | — | — | EP | disclosed |
| US-20120252741-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | BIOMARIN PHARMACEUTICAL INC. (US) | 2012-10-04 | — | — | US | disclosed |
| US-20100105607-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | LEAD THERAPEUTICS, INC. (US) | 2010-04-29 | — | — | US | disclosed |
| WO-2010048340-A2 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | LEAD THERAPEUTICS, INC. (US) | 2010-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105607-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | ASNS, ALG8, ALG1 | KCNA3 1600/4885SMN1; SMN2 3883/4885LTA4H 876/4885 |
| US-20120252741-A1 | NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS | ASNS, DNPEP, ALG8 | KCNA3 2290/4885SMN1; SMN2 3534/4885LTA4H 1125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.